Merit Financial Group, LLC Amarin Corp Plcuk Transaction History

Merit Financial Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 31, 2022	SELL	$1.09 - $1.67 $545 - $835	-500 Reduced 3.7%	13,000 $14,000
Q2 2022 Aug 08, 2022	BUY	$1.13 - $3.69 $15,254 - $49,815	13,500 New	13,500 $20,000
Q4 2020 Feb 12, 2021	SELL	$4.04 - $5.31 $25,411 - $33,399	-6,290 Closed	0 $0
Q3 2020 Nov 10, 2020	SELL	$3.64 - $7.76 $7,280 - $15,520	-2,000 Reduced 24.13%	6,290 $26,000
Q2 2020 Aug 13, 2020	SELL	$4.78 - $8.26 $5,258 - $9,086	-1,100 Reduced 11.71%	8,290 $57,000
Q1 2020 May 05, 2020	BUY	$4.0 - $21.53 $37,560 - $202,166	9,390 New	9,390 $38,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $222M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Merit Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Merit Financial Group, LLC with notifications on news.